文献速递头颈外科

头颈癌治疗前健康相关生活质量与生存的荟萃分析

Pretreatment Health-Related Quality of Life and Survival in Head and Neck Cancer: A Meta-Analysis.
PubMed 文献 · Laryngoscope · 2026-10-04

结果显示,较差的整体生活质量及躯体、角色、社会功能与死亡率升高持续相关,吞咽困难关联不稳定,呼吸困难异质性大。

要点

  • 治疗前整体生活质量及躯体、角色、社会功能较差与头颈癌患者死亡率升高持续相关。
  • 吞咽功能与死亡率关联存在敏感性,呼吸困难关联异质性大且不稳定。
  • 上述HRQoL领域可用于优先安排治疗前支持性照护评估,但低确定性发现不应作为治疗靶点。

核心结论

  • 治疗前HRQoL提供多维预后信息,整体生活质量和躯体、角色、情感、社会功能证据最一致。

研究设计与样本

  • 系统检索PubMed、Embase和Web of Science(建库至2026年7月27日),纳入评估经验证患者报告HRQoL作为预后暴露的纵向研究。
  • 采用限制性最大似然随机效应模型,将总生存调整风险比统一为每恶化10分的HR进行合并。

主要发现

  • 整体生活质量较差与死亡率升高相关(HR 1.11;95%CI 1.08-1.14),留一法稳定。
  • 躯体功能较差与死亡率升高相关(HR 1.16;95%CI 1.13-1.20),留一法稳定。
  • 角色功能较差与死亡率升高相关(HR 1.09;95%CI 1.07-1.11),留一法稳定。
  • 社会功能较差与死亡率升高相关(HR 1.09;95%CI 1.06-1.12),留一法稳定。
  • 吞咽功能与死亡率相关(HR 1.15;95%CI 1.02-1.29),但对单项研究敏感;呼吸困难主要分析关联(4项研究;HR 1.16;95%CI 1.01-1.33)异质且不稳定。

关键数值与推荐

  • 整体生活质量每恶化10分,总生存HR为1.11(95%CI 1.08-1.14)。
  • 躯体功能每恶化10分,总生存HR为1.16(95%CI 1.13-1.20)。
  • 角色功能每恶化10分,总生存HR为1.09(95%CI 1.07-1.11)。
  • 社会功能每恶化10分,总生存HR为1.09(95%CI 1.06-1.12)。

临床怎么用

  • 治疗前可评估整体生活质量及躯体、角色、社会功能,以识别预后较差、需优先支持性照护的患者。
  • 吞咽和呼吸困难等敏感性受限或极低确定性结果需进一步确认,不应作为可操作的治疗靶点。

局限性

  • 吞咽功能关联对单项研究敏感,呼吸困难估计异质且不稳定。
  • 部分领域证据确定性极低,需进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To quantify associations between pretreatment patient-reported health-related quality of life (HRQoL) domains and overall survival in head and neck cancer. DATA SOURCES: PubMed, Embase, and Web of Science were searched from inception through July 27, 2026. REVIEW METHODS: Longitudinal studies evaluating validated patient-reported HRQoL as a prognostic exposure were included. Adjusted hazard ratios (HRs) for overall survival were harmonized to a 10-point worsening and pooled by domain using restricted maximum-likelihood random-effects models. Risk of bias, multiplicity, leave-one-out stability, cohort overlap, residual-confounding sensitivity, and reporting completeness were evaluated. RESULTS: Thirty-two independent studies in 40 publications were included; 43 estimates contributed to meta-analyses of 10 domains. Worse Global QoL (HR, 1.11; 95% CI, 1.08-1.14), physical functioning (1.16; 1.13-1.20), role functioning (1.09; 1.07-1.11), and social functioning (1.09; 1.06-1.12) were consistently associated with higher mortality and remained leave-one-out stable. Swallowing was associated with mortality (1.15; 1.02-1.29) but was sensitive to one study. Dyspnea was associated with higher mortality in the primary analysis (4 studies; HR, 1.16; 95% CI, 1.01-1.33), but the estimate was heterogeneous and unstable. CONCLUSION: Pretreatment HRQoL provides multidimensional prognostic information, with Global QoL and physical, role, emotional, and social functioning showing the most consistent evidence. These domains may help prioritize pretreatment supportive-care assessment, whereas sensitivity-limited or very-low-certainty findings require further confirmation and should not be interpreted as actionable treatment targets. LEVEL OF EVIDENCE: N/A. TRIAL REGISTRATION: PROSPERO number: CRD420261461389.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Hu Y, Chu Q, Lin M, et al. Pretreatment Health-Related Quality of Life and Survival in Head and Neck Cancer: A Meta-Analysis. Laryngoscope. 2026. PMID: 42830661. doi:10.1002/lary.70960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。